Pages that link to "Q37993466"
Jump to navigation
Jump to search
The following pages link to Challenges in development of targeted liposomal therapeutics (Q37993466):
Displaying 50 items.
- Advances and Challenges of Liposome Assisted Drug Delivery (Q26773160) (← links)
- The potential of liposomes with carbonic anhydrase IX to deliver anticancer ingredients to cancer cells in vivo (Q26827175) (← links)
- Toward a magic or imaginary bullet? Ligands for drug targeting to cancer cells: principles, hopes, and challenges (Q26995399) (← links)
- Enhanced Specificity and Drug Delivery in Tumors by cRGD-Anchoring Thermosensitive Liposomes (Q27314854) (← links)
- SapC-DOPS nanovesicles as targeted therapy for lung cancer (Q28387728) (← links)
- Enhanced antitumor efficacy and reduced systemic toxicity of sulfatide-containing nanoliposomal doxorubicin in a xenograft model of colorectal cancer (Q28484922) (← links)
- Multimeric disintegrin protein polymer fusions that target tumor vasculature. (Q33901479) (← links)
- In vitro synergistic action of geldanamycin- and docetaxel-containing HPMA copolymer-RGDfK conjugates against ovarian cancer (Q34674722) (← links)
- Targeted delivery of polyamidoamine-paclitaxel conjugate functionalized with anti-human epidermal growth factor receptor 2 trastuzumab (Q35209810) (← links)
- Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery (Q35809872) (← links)
- Research and development in drug innovation: reflections from the 2013 bioeconomy conference in China, lessons learned and future perspectives (Q36110865) (← links)
- In vitro selection of random peptides against artificial lipid bilayers: a potential tool to immobilize molecules on membranes. (Q36300321) (← links)
- Tumor neovasculature-targeted cationic PEGylated liposomes of gambogic acid for the treatment of triple-negative breast cancer (Q37258973) (← links)
- GE11 peptide modified and reduction-responsive hyaluronic acid-based nanoparticles induced higher efficacy of doxorubicin for breast carcinoma therapy (Q37344290) (← links)
- Cholesterol--a biological compound as a building block in bionanotechnology. (Q38061564) (← links)
- Magnetoliposomes and their potential in the intelligent drug-delivery field (Q38074445) (← links)
- Oligonucleotide conjugates for therapeutic applications. (Q38123854) (← links)
- Current trends in the use of liposomes for tumor targeting (Q38126543) (← links)
- Applications of nanotechnology for melanoma treatment, diagnosis, and theranostics (Q38127412) (← links)
- Liposomal chemotherapeutics (Q38167883) (← links)
- The use of lipid-based nanocarriers for targeted pain therapies (Q38169707) (← links)
- In pursuit of a moving target: nanotherapeutics for the treatment of non-Hodgkin B-cell lymphoma (Q38253121) (← links)
- Nanotechnology in the management of cervical cancer (Q38370785) (← links)
- Advances in lipid-based drug delivery: enhancing efficiency for hydrophobic drugs (Q38406190) (← links)
- Current and emerging lipid-based systems for transdermal drug delivery (Q38590272) (← links)
- Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases. (Q38636886) (← links)
- Antibody-targeted biodegradable nanoparticles for cancer therapy (Q38665261) (← links)
- Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape (Q38825691) (← links)
- Technetium-99m radiolabeled paclitaxel as an imaging probe for breast cancer in vivo (Q38949920) (← links)
- Lipid-based nanocarriers for the oral administration of biopharmaceutics (Q38990887) (← links)
- Recent advances on liposomal nanoparticles: synthesis, characterization and biomedical applications. (Q39171230) (← links)
- Nanosized multifunctional liposomes for tumor diagnosis and molecular imaging by SPECT/CT. (Q39257035) (← links)
- Cyclic hexapeptide-conjugated nanoparticles enhance curcumin delivery to glioma tumor cells and tissue (Q41415544) (← links)
- Nanomaterials for the Capture and Therapeutic Targeting of Circulating Tumor Cells (Q42339249) (← links)
- Investigation of parameters influencing incorporation, retention and cellular cytotoxicity in liposomal formulations of poorly soluble camptothecin (Q44619320) (← links)
- The use of nanoparticulates to treat breast cancer (Q45066468) (← links)
- A wogonin-loaded glycyrrhetinic acid-modified liposome for hepatic targeting with anti-tumor effects (Q45356589) (← links)
- Ultrasonic energy in liposome production: process modelling and size calculation. (Q47178064) (← links)
- Surface Functionalization and Targeting Strategies of Liposomes in Solid Tumor Therapy: A Review (Q47190264) (← links)
- Targeting therapeutics to endothelium: are we there yet? (Q47250590) (← links)
- Nano-liposome-based target toxicity machine: an alternative/complementary approach in atopic diseases (Q47254471) (← links)
- Low-toxicity metallosomes for biomedical applications by self-assembly of organometallic metallosurfactants and phospholipids (Q48134969) (← links)
- Advantages and Limitations of Current Imaging Techniques for Characterizing Liposome Morphology (Q50275432) (← links)
- PNC27 anticancer peptide as targeting ligand significantly improved antitumor efficacy of Doxil in HDM2-expressing cells (Q50967733) (← links)
- PCM and TAT co-modified liposome with improved myocardium delivery: in vitro and in vivo evaluations (Q51016018) (← links)
- Docetaxel–trastuzumab stealth immunoliposome: development and in vitro proof of concept studies in breast cancer. (Q55285429) (← links)
- Destination Known: Targeted Drug Delivery in Atherosclerosis and Thrombosis (Q57342839) (← links)
- Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: A review. (Q57925206) (← links)
- Nanoencapsulation of Bacteriophages in Liposomes Prepared Using Microfluidic Hydrodynamic Flow Focusing (Q57929262) (← links)
- Synthesis and Purification of Homogeneous Lipid-Based Peptide Nanocarriers by Overcoming Phospholipid Ester Hydrolysis (Q58580939) (← links)